These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 25391288)

  • 21. Radiolabeled PLGA Nanoparticles for Effective Targeting of Bendamustine in Tumor Bearing Mice.
    Khan I; Gothwal A; Kaul A; Mathur R; Mishra AK; Gupta U
    Pharm Res; 2018 Aug; 35(11):200. PubMed ID: 30171428
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PLGA nanoparticles loaded with the antileishmanial saponin β-aescin: factor influence study and in vitro efficacy evaluation.
    Van de Ven H; Vermeersch M; Matheeussen A; Vandervoort J; Weyenberg W; Apers S; Cos P; Maes L; Ludwig A
    Int J Pharm; 2011 Nov; 420(1):122-32. PubMed ID: 21864661
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design and evaluation of poly(DL-lactic-co-glycolic acid) nanocomposite particles containing salmon calcitonin for inhalation.
    Yang M; Yamamoto H; Kurashima H; Takeuchi H; Yokoyama T; Tsujimoto H; Kawashima Y
    Eur J Pharm Sci; 2012 Aug; 46(5):374-80. PubMed ID: 22414702
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High loading efficiency and sustained release of siRNA encapsulated in PLGA nanoparticles: quality by design optimization and characterization.
    Cun D; Jensen DK; Maltesen MJ; Bunker M; Whiteside P; Scurr D; Foged C; Nielsen HM
    Eur J Pharm Biopharm; 2011 Jan; 77(1):26-35. PubMed ID: 21093589
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and characterization of doxorubicin-loaded poly(lactide-co-glycolide) nanoparticles as a sustained-release anticancer drug delivery system.
    Amjadi I; Rabiee M; Hosseini MS; Mozafari M
    Appl Biochem Biotechnol; 2012 Nov; 168(6):1434-47. PubMed ID: 22976852
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lappaconitine-loaded microspheres for parenteral sustained release: effects of formulation variables and in vitro characterization.
    Xu H; Zhong H; Liu M; Xu C; Gao Y
    Pharmazie; 2011 Sep; 66(9):654-61. PubMed ID: 22026119
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oral nuclear factor-κB decoy oligonucleotides delivery system with chitosan modified poly(D,L-lactide-co-glycolide) nanospheres for inflammatory bowel disease.
    Tahara K; Samura S; Tsuji K; Yamamoto H; Tsukada Y; Bando Y; Tsujimoto H; Morishita R; Kawashima Y
    Biomaterials; 2011 Jan; 32(3):870-8. PubMed ID: 20934748
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Formulation and evaluation of tacrolimus-loaded galactosylated Poly(lactic-co-glycolic acid) nanoparticles for liver targeting.
    Mistry NP; Desai JL; Thakkar HP
    J Pharm Pharmacol; 2015 Oct; 67(10):1337-48. PubMed ID: 25944126
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preparation and characterization of cationic PLGA nanospheres as DNA carriers.
    Ravi Kumar MN; Bakowsky U; Lehr CM
    Biomaterials; 2004 May; 25(10):1771-7. PubMed ID: 14738840
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Optimization of maghemite-loaded PLGA nanospheres for biomedical applications.
    Silva MF; Winkler Hechenleitner AA; de Oliveira DM; Agüeros M; Peñalva R; Irache JM; Pineda EA
    Eur J Pharm Sci; 2013 Jun; 49(3):343-51. PubMed ID: 23602998
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improved cellular uptake of chitosan-modified PLGA nanospheres by A549 cells.
    Tahara K; Sakai T; Yamamoto H; Takeuchi H; Hirashima N; Kawashima Y
    Int J Pharm; 2009 Dec; 382(1-2):198-204. PubMed ID: 19646519
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Paclitaxel loaded folic acid targeted nanoparticles of mixed lipid-shell and polymer-core: in vitro and in vivo evaluation.
    Zhao P; Wang H; Yu M; Liao Z; Wang X; Zhang F; Ji W; Wu B; Han J; Zhang H; Wang H; Chang J; Niu R
    Eur J Pharm Biopharm; 2012 Jun; 81(2):248-56. PubMed ID: 22446630
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In situ formation of chitosan-cyclodextrin nanospheres for drug delivery.
    Wang J; Zong JY; Zhao D; Zhuo RX; Cheng SX
    Colloids Surf B Biointerfaces; 2011 Oct; 87(1):198-202. PubMed ID: 21652181
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biodegradable nano-architectural PEGylated approach for the improved stability and anticancer efficacy of bendamustine.
    Khan I; Gothwal A; Sharma AK; Qayum A; Singh SK; Gupta U
    Int J Biol Macromol; 2016 Nov; 92():1242-1251. PubMed ID: 27527691
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunization against leishmaniasis by PLGA nanospheres encapsulated with autoclaved Leishmania major (ALM) and CpG-ODN.
    Tafaghodi M; Khamesipour A; Jaafari MR
    Parasitol Res; 2011 May; 108(5):1265-73. PubMed ID: 21125294
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chitosan-modified poly(D,L-lactide-co-glycolide) nanospheres for plasmid DNA delivery and HBV gene-silencing.
    Zeng P; Xu Y; Zeng C; Ren H; Peng M
    Int J Pharm; 2011 Aug; 415(1-2):259-66. PubMed ID: 21645597
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel hybrid delivery system: polymer-oil nanostructured carrier for controlled delivery of highly lipophilic drug all-trans-retinoic acid (ATRA).
    Narvekar M; Xue HY; Wong HL
    Int J Pharm; 2012 Oct; 436(1-2):721-31. PubMed ID: 22850294
    [TBL] [Abstract][Full Text] [Related]  

  • 38. G-CSF loaded biodegradable PLGA nanoparticles prepared by a single oil-in-water emulsion method.
    Choi SH; Park TG
    Int J Pharm; 2006 Mar; 311(1-2):223-8. PubMed ID: 16423477
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Budesonide Loaded PLGA Nanoparticles for Targeting the Inflamed Intestinal Mucosa--Pharmaceutical Characterization and Fluorescence Imaging.
    Ali H; Weigmann B; Collnot EM; Khan SA; Windbergs M; Lehr CM
    Pharm Res; 2016 May; 33(5):1085-92. PubMed ID: 26718953
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design of polymeric nanoparticles and its applications as drug delivery systems for acne treatment.
    Reis CP; Martinho N; Rosado C; Fernandes AS; Roberto A
    Drug Dev Ind Pharm; 2014 Mar; 40(3):409-17. PubMed ID: 23480566
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.